Zura Bio Limited (Nasdaq: ZURA) ("Zura"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and ...

Chinese pharmaceutical company WuXi XDC is partnering with U.S. biotech startup Earendil Labs in a deal it says could be worth up to $885 million. Under the agreement, Hong Kong-listed WuXi will grant ...

The stock of Tenax Therapeutics has surged following a corporate update and strong KOL support for TNX-103 in PH-HFpEF. Read the latest analysis on TENX here.

While the FDA mulls whether to approve Protagonist Therapeutics’ hematology asset, the biotech is thinking it will pocket $400 million rather than split U.S. profits with its partner Takeda. | While ...

The net proceeds from these warrant exercises, along with the net proceeds of approximately $141 million from the recent public offering that closed on February 20, 2026, and its existing cash and ...

As of Wednesday, February 25, United Therapeutics Corporation’s UTHR share price has surged by 10.84%, which has investors questioning if this is right time to sell.

Totaligent receives a binding call option to acquire 100% of GloMed (including JV interests) at any time during the one-year period following JV closing. The one-year option period allows time for a ...

After dumping its sole remaining gene therapy asset last year, Pfizer has decided to exercise its option for global rights to Beam Therapeutics’ liver-targeted gene editing candidate.

Novo Nordisk and China's United Biotechnology said an experimental obesity drug they are jointly developing helped patients ...

A growing body of preclinical research is converging on a provocative idea: that the mental health benefits of physical exercise might one day be delivered in pill form. Scientists have identified ...